NEW YORK (GenomeWeb) – Genomic services contract research organization Genewiz and Hy Laboratories today announced a partnership to develop diagnostic panels to characterize the gut microbiome in patients with obesity and diabetes.

The multiyear project seeks to stratify patients with diabetes and obesity for bariatric surgery or alternative treatments. Obesity and diabetes are closely related to the function and population of the gut microbiome, the firms said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.